The Cancer-Immune Set Point in Oesophageal Cancer

Immunotherapy has achieved long-term disease control in a proportion of cancer patients, but determinants of clinical benefit remain unclear. A greater understanding of antitumor immunity on an individual basis is needed to facilitate a precision oncology approach. A conceptual framework called the...

Descripción completa

Detalles Bibliográficos
Autores principales: Power, Robert, Lowery, Maeve A., Reynolds, John V., Dunne, Margaret R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287212/
https://www.ncbi.nlm.nih.gov/pubmed/32582553
http://dx.doi.org/10.3389/fonc.2020.00891

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7287212/
https://www.ncbi.nlm.nih.gov/pubmed/32582553
http://dx.doi.org/10.3389/fonc.2020.00891

Ejemplares similares